The synergistic impact of nonalcoholic fatty liver disease and metabolic syndrome on subclinical atherosclerosis

Nonalcoholic fatty liver disease (NAFLD) is a well‐known contributor for the development of cardiovascular disease (CVD). We examined the influence of NAFLD and metabolic syndrome (MetS) on markers of subclinical atherosclerosis, including carotid intima‐media thickness (CIMT), brachial–ankle pulse wave velocity (baPWV) and ankle–brachial pressure index (ABI), after adjusting for cardiometabolic risk factors.

[1]  International Association for the Study of Obesity , 2018, The Grants Register 2019.

[2]  J. Woo,et al.  2014 Clinical Practice Guidelines for Overweight and Obesity in Korea , 2014, Endocrinology and metabolism.

[3]  S. Fargion,et al.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art. , 2014, World journal of gastroenterology.

[4]  G. Cho,et al.  Non-alcoholic fatty liver disease, metabolic syndrome and subclinical cardiovascular changes in the general population , 2014, Heart.

[5]  S. Park,et al.  Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. , 2014, The Journal of clinical endocrinology and metabolism.

[6]  K. Sung,et al.  Arterial stiffness, fatty liver and the presence of coronary artery calcium in a large population cohort , 2013, Cardiovascular Diabetology.

[7]  L. Beilin,et al.  Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents , 2013, Hepatology.

[8]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[9]  M. Ermani,et al.  Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  Anoop Misra,et al.  Non-Alcoholic Fatty Liver Disease Is Closely Associated with Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India , 2013, PloS one.

[11]  H. J. Yoo,et al.  Body size phenotypes and low muscle mass: the Korean sarcopenic obesity study (KSOS). , 2013, The Journal of clinical endocrinology and metabolism.

[12]  J. Leipsic,et al.  The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. , 2013, Atherosclerosis.

[13]  F. Violi,et al.  Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS) , 2012, Internal and Emergency Medicine.

[14]  B. Kim,et al.  The Association between Nonalcoholic Fatty Liver Disease, Metabolic Syndrome and Arterial Stiffness in Nondiabetic, Nonhypertensive Individuals , 2012, Cardiology.

[15]  R. Pandey,et al.  Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. , 2012, Atherosclerosis.

[16]  Sihoon Lee,et al.  Association between brachial-ankle pulse wave velocity and occult coronary artery disease detected by multi-detector computed tomography. , 2012, International journal of cardiology.

[17]  Yu Xu,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[18]  T. Lehtimäki,et al.  Arterial pulse wave velocity in relation to carotid intima-media thickness, brachial flow-mediated dilation and carotid artery distensibility: the Cardiovascular Risk in Young Finns Study and the Health 2000 Survey. , 2012, Atherosclerosis.

[19]  R. Sladek,et al.  Characterizing the profile of obese patients who are metabolically healthy , 2011, International Journal of Obesity.

[20]  A. Benetos,et al.  Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study , 2010, Journal of hypertension.

[21]  G. Perseghin.  The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease , 2010, Digestive Diseases.

[22]  Greger Lindberg,et al.  Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up , 2010, Hepatology.

[23]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[24]  J. Cercueil,et al.  Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. , 2009, The Journal of clinical endocrinology and metabolism.

[25]  Fang-Chi Hsu,et al.  Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart Study , 2008, The American Journal of Gastroenterology.

[26]  Tetsuji Sato,et al.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. , 2006, Annals of internal medicine.

[27]  Emilio Ros,et al.  Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis: A Case–Control Study , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[28]  U. John,et al.  Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. , 2005, World journal of gastroenterology.

[29]  S. Baik,et al.  Relationship between serum adiponectin concentration, pulse wave velocity and nonalcoholic fatty liver disease. , 2005, European journal of endocrinology.

[30]  S. Baik,et al.  Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors of the metabolic syndrome. , 2004, Diabetes research and clinical practice.

[31]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[32]  A. Yamashina,et al.  Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[33]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[34]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.